当前位置:
X-MOL 学术
›
Eur. J. Clin. Investig.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Isoprostane-8 and GDF-15 as novel markers of post-PE syndrome: Relation with prothrombotic factors
European Journal of Clinical Investigation ( IF 4.4 ) Pub Date : 2021-07-27 , DOI: 10.1111/eci.13660 Michał Ząbczyk 1, 2 , Joanna Natorska 1, 2 , Agnieszka Janion-Sadowska 3 , Agnieszka Metzgier-Gumiela 4 , Mateusz Polak 5 , Krzysztof Plens 6 , Marianna Janion 3 , Grzegorz Skonieczny 4 , Katarzyna Mizia-Stec 5 , Anetta Undas 1, 2
European Journal of Clinical Investigation ( IF 4.4 ) Pub Date : 2021-07-27 , DOI: 10.1111/eci.13660 Michał Ząbczyk 1, 2 , Joanna Natorska 1, 2 , Agnieszka Janion-Sadowska 3 , Agnieszka Metzgier-Gumiela 4 , Mateusz Polak 5 , Krzysztof Plens 6 , Marianna Janion 3 , Grzegorz Skonieczny 4 , Katarzyna Mizia-Stec 5 , Anetta Undas 1, 2
Affiliation
Post–pulmonary embolism (PE) syndrome occurs in up to 50% of PE patients. The pathophysiology of this syndrome is obscure.
中文翻译:
Isoprostane-8 和 GDF-15 作为 PE 后综合征的新标志物:与促血栓形成因素的关系
高达 50% 的 PE 患者出现肺栓塞后 (PE) 综合征。该综合征的病理生理学尚不清楚。
更新日期:2021-07-27
中文翻译:
Isoprostane-8 和 GDF-15 作为 PE 后综合征的新标志物:与促血栓形成因素的关系
高达 50% 的 PE 患者出现肺栓塞后 (PE) 综合征。该综合征的病理生理学尚不清楚。